Skip to main content
Premium Trial:

Request an Annual Quote

Predictive Diagnostics Closes Doors as Nasdaq Delists LSBC

NEW YORK, Jan. 3 (GenomeWeb News) - Faced with delisting from the Nasdaq exchange, Large Scale Biology has shuttered its operations, including its proteomics subsidiary, Predictive Diagnostics, GenomeWeb News has learned.

 

LSBC disclosed its plan in a filing with the Securities Exchange Commission. Though the filing did not mention Predictive Diagnostics' fate, when GenomeWeb News called the company for details today a recorded message said, "Effective December 23, 2005, Predictive Diagnostics, Inc. has ceased operations. Calls to this number will not be returned."

 

GenomeWeb News has reported LSBC's financial woes in the past. After its stock price plummeted to less than $1 per share in June, Nasdaq threatened to delist the company unless the share price went back up in 180 days.

 

According to the SEC filing, LSBC's stock ceased trading at the end of trading on Dec. 23.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.